ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.1050
-0.0110 (-9.48%)
At close: Jul 30, 2026
ZyVersa Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 |
Net Income | -1.79 | -0.68 | -19.81 | -2.21 | -2.26 | -1.42 | -2.4 | -2.76 | -2.83 | -13.34 | -2.9 | -78.51 | -3.54 | -4.68 | -3.69 | -2 | -3.75 | -1.97 | -1.88 | -2.1 |
Depreciation & Amortization | - | - | - | - | - | - | 0 | 0 | 0 | -0.11 | 0.12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Amortization | - | 0.06 | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0.03 | 0.07 | 0.09 | 0.08 |
Asset Writedown & Restructuring Costs | - | - | 18.65 | - | - | - | - | - | - | 12.16 | - | 81.18 | - | - | - | - | - | - | - | - |
Stock-Based Compensation | 0.06 | 0.02 | 0.07 | 0.06 | 0.15 | 0.16 | 0.16 | 0.16 | 0.22 | 0.3 | 0.24 | 0.37 | 0.29 | 0.45 | 0.49 | 0.7 | 1.94 | 0.82 | 1.4 | 1.03 |
Other Operating Activities | 0.36 | - | -0.82 | 0.13 | - | 0.11 | - | 0.01 | 0.09 | -0.39 | -0.09 | -6.45 | -0.63 | -0.47 | 0.19 | 0 | 0.23 | -0.01 | -0.46 | 0.02 |
Change in Accounts Payable | 0.11 | 0.32 | 0.31 | -0.14 | 0.19 | 0.21 | 0.79 | 0.19 | -0.3 | -0.47 | 0.75 | 1.76 | 0.36 | 1.09 | 1.24 | 0.97 | 1.23 | 0.37 | -0.02 | -0.31 |
Change in Other Net Operating Assets | 0.47 | -0.13 | 0.18 | 0.64 | 0.14 | -0.28 | 0.83 | 0.49 | -0.96 | -0.93 | 0.94 | 1.25 | -1.06 | -0.2 | 1.37 | 0.01 | -0.07 | 0.11 | 0.17 | -0.23 |
Operating Cash Flow | -0.8 | -0.41 | -1.41 | -1.52 | -1.77 | -1.21 | -0.61 | -1.91 | -3.78 | -2.79 | -0.94 | -0.41 | -4.59 | -3.81 | -0.39 | -0.32 | -0.37 | -0.62 | -0.7 | -1.5 |
Operating Cash Flow Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Long-Term Debt Issued | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Debt Issued (Repaid) | 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Issuance of Common Stock | - | - | 2.05 | 0 | - | 3.04 | 0.83 | - | 2.67 | 5 | 3.07 | 11.02 | - | - | - | - | - | - | - | - |
Repurchase of Common Stock | - | - | - | - | - | - | - | - | - | - | - | -0.01 | - | - | - | - | - | - | - | - |
Other Financing Activities | - | -0.01 | -0.19 | -0.02 | 1.85 | -0.42 | -0.21 | - | - | -0.65 | -0.55 | -1.18 | -0.03 | -0.04 | -0.33 | 0.3 | -0.03 | - | - | - |
Financing Cash Flow | 1 | -0.01 | 1.86 | -0.02 | 1.85 | 2.62 | 0.62 | - | 2.67 | 4.35 | 2.29 | -0.64 | -0.03 | 0.51 | 0.66 | 0.3 | 0.39 | - | - | - |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | - | - | - | - | - | -0 | 0 | - | - | - | - | - | - | - | - |
Net Cash Flow | 0.2 | -0.43 | 0.46 | -1.54 | 0.08 | 1.41 | 0 | -1.91 | -1.1 | 1.56 | 1.35 | -1.05 | -4.62 | -3.3 | 0.27 | -0.02 | 0.02 | -0.62 | -0.7 | -1.5 |
Levered Free Cash Flow | -0.1 | -0.16 | -1.24 | -0.59 | -0.8 | -0.96 | 0.46 | -0.8 | -2.79 | -2.2 | 0.33 | -0.25 | -3.26 | -3.79 | 0.67 | 0.36 | 1.1 | - | - | - |
Unlevered Free Cash Flow | -0.02 | -0.08 | -1.16 | -0.51 | -0.73 | -0.87 | 0.55 | -0.8 | -2.79 | -2.2 | 0.33 | -0.25 | -3.26 | -3.76 | 0.71 | 0.45 | 1.18 | - | - | - |
Change in Working Capital | 0.58 | 0.19 | 0.5 | 0.5 | 0.33 | -0.07 | 1.62 | 0.68 | -1.26 | -1.4 | 1.7 | 3.01 | -0.71 | 0.89 | 2.62 | 0.98 | 1.17 | 0.47 | 0.15 | -0.54 |